Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 38 studies | 49% ± 22% | |
| pericyte | 20 studies | 42% ± 20% | |
| smooth muscle cell | 16 studies | 38% ± 20% | |
| microglial cell | 16 studies | 55% ± 16% | |
| oligodendrocyte precursor cell | 13 studies | 37% ± 12% | |
| astrocyte | 13 studies | 39% ± 18% | |
| fibroblast | 12 studies | 34% ± 14% | |
| macrophage | 12 studies | 34% ± 13% | |
| capillary endothelial cell | 12 studies | 34% ± 17% | |
| GABAergic neuron | 11 studies | 63% ± 24% | |
| glutamatergic neuron | 11 studies | 75% ± 18% | |
| ciliated cell | 10 studies | 36% ± 20% | |
| endothelial cell of lymphatic vessel | 9 studies | 48% ± 17% | |
| oligodendrocyte | 9 studies | 30% ± 16% | |
| type I pneumocyte | 8 studies | 49% ± 23% | |
| retinal rod cell | 8 studies | 53% ± 32% | |
| epithelial cell | 8 studies | 46% ± 19% | |
| adipocyte | 8 studies | 32% ± 12% | |
| vein endothelial cell | 8 studies | 41% ± 22% | |
| neuron | 7 studies | 52% ± 21% | |
| amacrine cell | 7 studies | 38% ± 25% | |
| retinal ganglion cell | 7 studies | 58% ± 27% | |
| retinal cone cell | 7 studies | 61% ± 30% | |
| interneuron | 6 studies | 68% ± 17% | |
| retina horizontal cell | 6 studies | 51% ± 23% | |
| cardiac muscle cell | 6 studies | 58% ± 24% | |
| basal cell | 6 studies | 32% ± 24% | |
| mesothelial cell | 5 studies | 31% ± 12% | |
| endothelial cell of vascular tree | 5 studies | 45% ± 17% | |
| myeloid cell | 5 studies | 43% ± 21% | |
| type II pneumocyte | 5 studies | 34% ± 8% | |
| squamous epithelial cell | 4 studies | 40% ± 24% | |
| cholangiocyte | 4 studies | 50% ± 20% | |
| granule cell | 4 studies | 42% ± 27% | |
| dendritic cell | 4 studies | 29% ± 10% | |
| Mueller cell | 4 studies | 38% ± 15% | |
| monocyte | 4 studies | 36% ± 28% | |
| alveolar macrophage | 4 studies | 51% ± 18% | |
| club cell | 4 studies | 23% ± 3% | |
| endothelial cell of sinusoid | 3 studies | 38% ± 11% | |
| hepatic stellate cell | 3 studies | 57% ± 13% | |
| glomerular endothelial cell | 3 studies | 36% ± 7% | |
| GABAergic interneuron | 3 studies | 70% ± 0% | |
| endothelial cell of artery | 3 studies | 23% ± 5% | |
| GABAergic amacrine cell | 3 studies | 50% ± 14% | |
| OFF-bipolar cell | 3 studies | 51% ± 3% | |
| ON-bipolar cell | 3 studies | 44% ± 7% | |
| glycinergic amacrine cell | 3 studies | 57% ± 7% | |
| myofibroblast cell | 3 studies | 38% ± 9% | |
| hepatocyte | 3 studies | 33% ± 12% | |
| retinal pigment epithelial cell | 3 studies | 47% ± 15% | |
| connective tissue cell | 3 studies | 35% ± 14% | |
| ependymal cell | 3 studies | 53% ± 6% | |
| mast cell | 3 studies | 33% ± 10% | |
| goblet cell | 3 studies | 47% ± 30% | |
| transit amplifying cell | 3 studies | 43% ± 37% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 3199.89 | 1445 / 1445 | 99% | 15.52 | 182 / 183 |
| breast | 100% | 4815.86 | 459 / 459 | 98% | 10.52 | 1097 / 1118 |
| lung | 100% | 4551.14 | 578 / 578 | 98% | 8.60 | 1133 / 1155 |
| intestine | 100% | 2157.30 | 963 / 966 | 97% | 7.50 | 513 / 527 |
| skin | 100% | 4106.45 | 1809 / 1809 | 95% | 9.56 | 450 / 472 |
| bladder | 100% | 2776.52 | 21 / 21 | 94% | 6.58 | 473 / 504 |
| uterus | 100% | 3559.75 | 170 / 170 | 93% | 7.81 | 429 / 459 |
| brain | 95% | 2020.27 | 2502 / 2642 | 97% | 8.36 | 687 / 705 |
| kidney | 100% | 2028.39 | 89 / 89 | 92% | 8.78 | 825 / 901 |
| stomach | 94% | 1474.75 | 338 / 359 | 97% | 9.05 | 278 / 286 |
| ovary | 99% | 1987.34 | 178 / 180 | 92% | 5.09 | 397 / 430 |
| thymus | 100% | 3137.42 | 652 / 653 | 91% | 6.51 | 550 / 605 |
| prostate | 100% | 2255.84 | 244 / 245 | 88% | 6.11 | 440 / 502 |
| pancreas | 88% | 1061.57 | 289 / 328 | 98% | 10.48 | 174 / 178 |
| adrenal gland | 98% | 1658.32 | 252 / 258 | 81% | 4.75 | 187 / 230 |
| adipose | 100% | 5100.72 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 6086.68 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.25 | 1 / 1 |
| heart | 99% | 3322.67 | 855 / 861 | 0% | 0 | 0 / 0 |
| liver | 39% | 349.96 | 89 / 226 | 58% | 3.84 | 237 / 406 |
| spleen | 95% | 1474.54 | 230 / 241 | 0% | 0 | 0 / 0 |
| muscle | 94% | 1280.38 | 757 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 6.67 | 42 / 45 |
| eye | 0% | 0 | 0 / 0 | 75% | 3.79 | 60 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 14% | 0.36 | 4 / 29 |
| peripheral blood | 0% | 0.70 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007165 | Biological process | signal transduction |
| GO_0010467 | Biological process | gene expression |
| GO_2000257 | Biological process | regulation of protein activation cascade |
| GO_0035264 | Biological process | multicellular organism growth |
| GO_0009749 | Biological process | response to glucose |
| GO_0002021 | Biological process | response to dietary excess |
| GO_0060612 | Biological process | adipose tissue development |
| GO_0005829 | Cellular component | cytosol |
| GO_0005515 | Molecular function | protein binding |
| GO_0005096 | Molecular function | GTPase activator activity |
| Gene name | RASAL2 |
| Protein name | RAS protein activator like 2 RASAL2 protein Ras GTPase-activating protein nGAP (RAS protein activator-like 2) |
| Synonyms | NGAP |
| Description | FUNCTION: Inhibitory regulator of the Ras-cyclic AMP pathway. |
| Accessions | ENST00000433130.2 ENST00000696607.1 A0A8Q3SIZ5 ENST00000696606.1 A0A8Q3SIU1 A0A8Q3SJF6 H0Y638 Q6P4F9 ENST00000696605.1 ENST00000462775.5 [Q9UJF2-1] Q9UJF2 ENST00000367649.8 [Q9UJF2-2] |